Related Experiment Videos
Melphalan and methotrexate in advanced breast cancer
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Palliative radiotherapy in the UK.
The Canadian journal of oncology·1996
The role of palliative radiotherapy for bone metastases.
The Canadian journal of oncology·1996
Controlling the toxicity of palliative radiotherapy: the role of 5-HT3 antagonists.
The Canadian journal of oncology·1996
Final results of the Royal College of Radiologists' trial comparing two different radiotherapy schedules in the treatment of cerebral metastases.
Clinical oncology (Royal College of Radiologists (Great Britain))·1996
A prospective randomized trial to evaluate different oral dose regimens of medroxyprogesterone acetate in women with advanced breast cancer.
Clinical oncology (Royal College of Radiologists (Great Britain))·1995
Lymphoma of the prostate treated with radiotherapy.
Clinical oncology (Royal College of Radiologists (Great Britain))·1995
Cisplatin as a first-line treatment in T2 and T3 bladder carcinoma.
Cancer treatment reports·1987
IV melphalan in children.
Cancer treatment reports·1987
Interactions of methotrexate and cyclophosphamide with the pharmacokinetics of 5-fluorouracil in an animal model.
Cancer treatment reports·1987
Phase II trial of rDNA alfa 2b interferon in patients with malignant carcinoid tumor.
Cancer treatment reports·1987
Doxorubicin distribution in human breast cancer.
Cancer treatment reports·1987
Phase I study of echinomycin.
Cancer treatment reports·1987
First-line sugemalimab plus chemotherapy for metastatic non-small-cell lung cancer: an updated cost-effectiveness analysis based on 4-year survival data.
Expert review of pharmacoeconomics & outcomes research·2026
Survival Benefit of ARSI Therapy in Japanese mCSPC: A Systematic Review and Meta-Analysis.
International journal of urology : official journal of the Japanese Urological Association·2026
Patterns of radiological response to procarbazine and CCNU polychemotherapy in patients with oligodendroglioma.
Neuro-oncology advances·2026